2909 Laclede Ave
63103
St. Louis, MO
https://www.sigmaaldrich.com/US/en/home
Show place in map
Non-Members: $60
*Please note: Registration at the door is $60
*Online registration closes on March 10 at 3:00 PM CT.
Ticket includes GABO survey results presentation/panel discussion and appetizers/refreshments.
Join us at MilliporeSigma on March 11 for the live presentation and discussion of the results of the German American Business Outlook (GABO) survey, and learn what German companies in the US predict for the coming year.
What are the biggest challenges German subsidiaries in the US face in 2025? What’s going well?
The German American Business Outlook (GABO) is an annual survey of German-American business relations directed at German subsidiaries in the US assessing current economic developments and trends in transatlantic business.
Join us in St. Louis, Missouri at MilliporeSigma on March 11 for the live presentation and discussion of the results of the German American Business Outlook (GABO) survey, and learn what German companies in the US predict for the coming year.
Conducted by the German American Chambers of Commerce, this US-wide survey is one of the most important economic indicators of German American business relations.
Our panel of executives will discuss the results of the survey and what they mean for German subsidiaries in the Midwest.
Event Host Company - MilliporeSigma
At Merck KGaA around 63,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck KGaA, Darmstadt, Germany, generated sales of € 21 billion in 65 countries.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 27,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services.
